HK1054942A1 - Bicyclic heteroaromatic compounds - Google Patents

Bicyclic heteroaromatic compounds

Info

Publication number
HK1054942A1
HK1054942A1 HK03107319A HK03107319A HK1054942A1 HK 1054942 A1 HK1054942 A1 HK 1054942A1 HK 03107319 A HK03107319 A HK 03107319A HK 03107319 A HK03107319 A HK 03107319A HK 1054942 A1 HK1054942 A1 HK 1054942A1
Authority
HK
Hong Kong
Prior art keywords
heteroaromatic compounds
bicyclic heteroaromatic
bicyclic
compounds
heteroaromatic
Prior art date
Application number
HK03107319A
Other languages
English (en)
Inventor
Cornelis Marius Timmers
Willem Frederik Johan Karstens
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of HK1054942A1 publication Critical patent/HK1054942A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK03107319A 2000-09-22 2003-10-13 Bicyclic heteroaromatic compounds HK1054942A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203287 2000-09-22
PCT/EP2001/010743 WO2002024703A1 (fr) 2000-09-22 2001-09-17 Composés hétéroaromatique bicyclique

Publications (1)

Publication Number Publication Date
HK1054942A1 true HK1054942A1 (en) 2003-12-19

Family

ID=8172046

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03107319A HK1054942A1 (en) 2000-09-22 2003-10-13 Bicyclic heteroaromatic compounds

Country Status (32)

Country Link
US (2) US7229990B2 (fr)
EP (2) EP1322651B1 (fr)
JP (1) JP4977940B2 (fr)
KR (1) KR100860040B1 (fr)
CN (1) CN1247594C (fr)
AR (1) AR030784A1 (fr)
AT (1) ATE384726T1 (fr)
AU (2) AU2002213929B2 (fr)
BR (1) BR0113987A (fr)
CA (1) CA2422054C (fr)
CY (1) CY1107308T1 (fr)
CZ (1) CZ297136B6 (fr)
DE (1) DE60132607T2 (fr)
DK (1) DK1322651T3 (fr)
EC (1) ECSP034523A (fr)
ES (1) ES2299524T3 (fr)
HK (1) HK1054942A1 (fr)
HR (1) HRP20030220B1 (fr)
HU (1) HU229422B1 (fr)
IL (2) IL154624A0 (fr)
IS (1) IS2531B (fr)
MX (1) MXPA03002478A (fr)
NO (1) NO328683B1 (fr)
NZ (1) NZ524444A (fr)
PE (1) PE20020537A1 (fr)
PL (1) PL207755B1 (fr)
PT (1) PT1322651E (fr)
RU (1) RU2271360C2 (fr)
SK (1) SK287554B6 (fr)
TW (1) TWI290143B (fr)
WO (1) WO2002024703A1 (fr)
ZA (1) ZA200301588B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002213929B2 (en) * 2000-09-22 2006-04-13 Merck Sharp & Dohme B.V. Bicyclic heteroaromatic compounds
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
BRPI0610133A2 (pt) * 2005-05-17 2010-06-01 Schering Corp heterociclos como agonistas de receptor de ácido nicotìnico para o tratamento de dislipidemia
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
CA2652061A1 (fr) * 2006-05-17 2007-11-29 Marvin C. Gershengorn Ligands de pyrimidine de faible poids moleculaire destines a moduler des recepteurs hormonaux
CN102015704A (zh) 2008-04-29 2011-04-13 霍夫曼-拉罗奇有限公司 Jnk的嘧啶基吡啶酮抑制剂
EP2358684B8 (fr) 2008-10-20 2014-10-22 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Agonistes de faible poids moléculaire du récepteur de l hormone stimulatrice de la thyroïde (tshr)
EP2563777A4 (fr) 2010-04-08 2013-09-04 Us Health Agonistes inverses et antagonistes neutres pour récepteur du tsh
CN103974955B (zh) 2011-08-23 2018-06-19 阿萨纳生物科技有限责任公司 嘧啶并-哒嗪酮化合物及其用途
CN113680386B (zh) * 2021-08-23 2023-08-11 深圳湾实验室坪山生物医药研发转化中心 氮杂环卡宾-方酰胺双功能催化剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL181895B1 (pl) 1994-06-16 2001-10-31 Pfizer Nowe pirazolo-i pirolopirydyny _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ PL PL PL PL
WO1997044041A1 (fr) * 1996-05-20 1997-11-27 Merck & Co., Inc. Antagonistes de la gonadoliberine
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
AU2002213929B2 (en) * 2000-09-22 2006-04-13 Merck Sharp & Dohme B.V. Bicyclic heteroaromatic compounds

Also Published As

Publication number Publication date
NO328683B1 (no) 2010-04-26
DE60132607T2 (de) 2009-01-29
KR100860040B1 (ko) 2008-09-25
SK287554B6 (sk) 2011-01-04
NO20031314L (no) 2003-03-21
DE60132607D1 (de) 2008-03-13
EP1886999A2 (fr) 2008-02-13
ES2299524T3 (es) 2008-06-01
PE20020537A1 (es) 2002-06-20
ECSP034523A (es) 2003-04-25
PL360675A1 (en) 2004-09-20
NZ524444A (en) 2004-03-26
US7618963B2 (en) 2009-11-17
EP1886999A3 (fr) 2008-03-12
HU229422B1 (hu) 2013-12-30
HRP20030220B1 (en) 2011-10-31
IS2531B (is) 2009-07-15
US20070197527A1 (en) 2007-08-23
AR030784A1 (es) 2003-09-03
WO2002024703A1 (fr) 2002-03-28
BR0113987A (pt) 2003-08-12
HRP20030220A2 (en) 2003-06-30
AU2002213929B2 (en) 2006-04-13
HUP0302648A2 (hu) 2003-11-28
JP2004509896A (ja) 2004-04-02
EP1886999A8 (fr) 2010-08-04
DK1322651T3 (da) 2008-06-02
IL154624A0 (en) 2003-09-17
CZ2003828A3 (cs) 2003-08-13
US7229990B2 (en) 2007-06-12
ATE384726T1 (de) 2008-02-15
ZA200301588B (en) 2004-06-22
CN1462273A (zh) 2003-12-17
EP1322651B1 (fr) 2008-01-23
CY1107308T1 (el) 2012-11-21
KR20030040483A (ko) 2003-05-22
CA2422054A1 (fr) 2002-03-28
EP1322651A1 (fr) 2003-07-02
CA2422054C (fr) 2011-01-11
RU2271360C2 (ru) 2006-03-10
IL154624A (en) 2009-09-01
SK3312003A3 (en) 2003-08-05
JP4977940B2 (ja) 2012-07-18
NO20031314D0 (no) 2003-03-21
CZ297136B6 (cs) 2006-09-13
AU1392902A (en) 2002-04-02
IS6732A (is) 2003-02-28
TWI290143B (en) 2007-11-21
MXPA03002478A (es) 2004-05-05
PT1322651E (pt) 2008-02-28
US20030225113A1 (en) 2003-12-04
CN1247594C (zh) 2006-03-29
HUP0302648A3 (en) 2004-11-29
PL207755B1 (pl) 2011-01-31

Similar Documents

Publication Publication Date Title
EP1349851A4 (fr) Composes
GB0027987D0 (en) Compounds
IL154624A0 (en) Bicyclic heteroaromatic compounds
AU2405002A (en) Dehalogeno compounds
PL369829A1 (en) Substituted 1h-quinolin-2-one compounds
GB0015853D0 (en) Compounds
GB0009457D0 (en) Compounds
GB0006797D0 (en) Compounds
GB0018351D0 (en) Compounds
GB0027784D0 (en) Compounds
GB0002969D0 (en) Compounds
GB0003140D0 (en) Compounds
GB0018306D0 (en) Compounds
GB0015902D0 (en) Compounds
GB0015863D0 (en) Compounds
GB0006454D0 (en) Compounds
GB0015852D0 (en) Compounds
GB0003598D0 (en) Compounds
GB0014823D0 (en) Compounds
GB0014652D0 (en) Compounds
GB0014642D0 (en) Compounds
GB0014641D0 (en) Compounds
GB0004053D0 (en) Compounds
GB0009456D0 (en) Compounds
GB0008728D0 (en) Compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150917